We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current NVS market cap is 212.99B. The company's latest EPS is USD 6.0458 and P/E is 18.39.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 20.09B | 11.83B | 13.16B | 12.17B | 14.56B |
| Operating Income | 2.84B | 3.34B | 4.01B | 3.62B | 3.53B |
| Net Income | 8.48B | 2.69B | 3.25B | 3.19B | 2.82B |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 49.9B | 52.88B | 51.83B | 54.11B | 51.72B |
| Operating Income | 10.83B | 27.03B | 9.19B | 10.02B | 14.51B |
| Net Income | 8.07B | 24.02B | 6.96B | 14.85B | 11.94B |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 99.95B | 94.33B | 97.51B | 103.52B | 102.25B |
| Total Liabilities | 53.2B | 54.58B | 55.6B | 60.08B | 58.12B |
| Total Equity | 46.75B | 39.76B | 41.9B | 43.44B | 44.13B |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 132.06B | 131.8B | 117.45B | 99.95B | 102.25B |
| Total Liabilities | 75.39B | 63.97B | 58.03B | 53.2B | 58.12B |
| Total Equity | 56.67B | 67.82B | 59.42B | 46.75B | 44.13B |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 9.84B | 2.27B | 7.14B | 13.43B | 17.62B |
| Investing | N/A | -899M | -4.11B | -4.48B | -7.51B |
| Financing | N/A | -5.16B | -8.36B | -8.75B | -11.74B |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 13.65B | 15.07B | 14.24B | 9.84B | 17.62B |
| Investing | -13.18B | 4.21B | 1.47B | N/A | -7.51B |
| Financing | -2.21B | -16.26B | -20.56B | N/A | -11.74B |
| Market Cap | 212.99B |
| Price to Earnings Ratio | 18.39 |
| Price to Sales Ratio | 4.24 |
| Price to Cash Ratio | 19.16 |
| Price to Book Ratio | 4.98 |
| Dividend Yield | - |
| Shares Outstanding | 1.98B |
| Average Volume (1 week) | 2.51M |
| Average Volume (1 Month) | 2.35M |
| 52 Week Change | 3.12% |
| 52 Week High | 120.92 |
| 52 Week Low | 92.35 |
| Spread (Intraday) | 0.03 (0.03%) |
| Company Name | Novartis AG |
| Address |
po box basel 4002 |
| Website | https://www.novartis.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
